Sera Prognostics, Sonrava Health, Cerebrae partner on preterm birth risk

Hospital Baby Nurse

Sera Prognostics said on Tuesday that it is collaborating with health and wellness firm Sonrava Health and Cerebrae, a specialist in pricing and measuring care-product financial value, to provide Sera's PreTRM Test to members of Sonrava Health's employer-sponsored health insurance program.

The PreTRM blood test provides an early, individual risk assessment for spontaneous preterm birth in asymptomatic singleton pregnancies. It identifies nearly 90% of pregnancies where spontaneous preterm deliveries will occur, enabling earlier proactive intervention to improve the well-being of mothers and babies, Sera said.

Cerebrae has developed a technology platform that leverages actuarial and data science to forecast financial risk and monitor a healthcare product's performance. The Cerebrae Platform provides actuarially rigorous risk-management capabilities enabling participants in the healthcare ecosystem to enter into a value-based arrangement, Sera said.

Using the Cerebrae Platform, Sonrava Health has generated a forecast of the financial return on investment that employees and their families can expect by using the PreTRM Test, Sera added.

Page 1 of 34
Next Page